Vical approves reverse stock split and merger with Brickell


Vical (VICL -20%) approves the proposal to merge with Brickell Biotech and the transaction is expected to close on August 31, 2019.

Vical expects to change its name from “Vical Incorporated” to “Brickell Biotech, Inc.”

Also, its stock expected to begin trading on the Nasdaq under the stock symbol “BBI” on Tuesday, September 3, 2019.

Vical has also determined, that the reverse stock split of common stock will be effected at a ratio of 1-for-7 and is expected to be completed immediately prior to the consummation of the Merger.





READ SOURCE

READ  There's still uncertainty about extra borrowing towards year-end: Mahendra Jajoo, Mirae Global

LEAVE A REPLY

Please enter your comment!
Please enter your name here